Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Trading Up ?
The company has a fifty day moving average of C$2.00 and a 200-day moving average of C$2.00. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The company has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Stories
- Five stocks we like better than Liberty Biopharma
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- ETF Screener: Uses and Step-by-Step Guide
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Options Trading – Understanding Strike Price
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
